A new study lays the groundwork for considering time burden as an adverse event in cancer trials. This study summary was published on medrxiv.org as a preprint and has not yet been peer reviewed.
First Look
A new study lays the groundwork for considering time burden as an adverse event in cancer trials. This study summary was published on medrxiv.org as a preprint and has not yet been peer reviewed.
First Look
